Status:
COMPLETED
Bleomycin Intralesional Injections of Cystic Hygromas
Lead Sponsor:
Delta University for Science and Technology
Conditions:
Lymphatic Malformations
Eligibility:
All Genders
1-12 years
Phase:
NA
Brief Summary
Thirty pediatric patients with cystic hygromas participated in this study. The cystic fluid was aspirated from the cystic hygroma, and the lesion was simultaneously injected with Bleomycin. Then, the ...
Detailed Description
A total of 30 pediatric patients of age up to 12 years having Cervicofacial cystic hygromas (macrocystic lymphatic malformations) were chosen from the vascular anomalies clinic in Cairo University Spe...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Cervicofacial cystic hygromas (macrocystic lymphatic malformations) Pediatric patients from age 1 month to 12 years, recruited from the vascular anomalies clinic at the pediatric surgery department in Cairo University Specialized Pediatric Hospital (Abu EL-Reesh hospital).
Exclusion
- lung disease cardiac disease Liver disease kidney disease
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07189832
Start Date
September 1 2024
End Date
April 1 2025
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University Specialized Pediatric Hospital (Abu EL-Reesh hospital)
Cairo, Egypt, 12613